Boston Scientific discontinues angiographic catheters
Boston Scientific removes angiographic and imaging catheters from the market following high-severity device recalls and safety alerts.
4 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 4 separate news trends connected to Medtech, spanning July 15, 2026 through September 2, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 33 article observations and 32 source signals, led by Business, Technology coverage. Use it to compare how individual events emerged, spread and changed over time.
Boston Scientific removes angiographic and imaging catheters from the market following high-severity device recalls and safety alerts.
The FDA has granted authorization to Vitestro’s Aletta, the first autonomous robotic device capable of performing blood draws without human intervention.
CipherX has launched a new microdot tool designed to provide permanent tattoos without the pain associated with traditional needles.
Johnson & Johnson has exceeded quarterly earnings estimates and raised its financial guidance, driven by a strong performance in its medicines unit.